Mindful After Cancer: A Mindfulness-based Therapy Intervention for Sexual Health After Cancer
Part of paid clinical trials in Corvallis, Oregon.
- Sponsor
- Oregon State University
- Study ID
- NCT04559854
- Status
- Completed
Conditions
- Breast Cancer
- Gynecologic Cancer
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- Mindful After Cancer — BEHAVIORALThe intervention includes eight weekly sessions (1.5-2 hours each), plus participant educational materials and audio recorded meditations, and is delivered to women in their homes via group videoconference led by a trained facilitator. Participants are asked to complete activities and mindfulness practice between sessions.
Study Details
The objectives of this study are to: 1) adapt a mindfulness-based therapy program designed to help women manage their sexual and body image concerns after cancer (Mindful After Cancer, MAC) to a videoconference format and 2) assess the feasibility, acceptability, and preliminary effects of the program among breast and gynecologic cancer survivors.
Key Dates
- Start date
- Jul 1, 2019
- Status verified
- Jun 2025
- Primary completion
- Oct 1, 2020
- Completion
- Oct 5, 2020
Study Design
- Enrollment
- 22 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Mindful After CancerParticipants will be asked to attend 8 weekly sessions via videoconference, and to complete home activities and mindfulness practice between sessions.
Primary Outcome Measure
Feasibility/ Enrollment in the Study [ Time Frame: Baseline (T1) ]
Locations (1)
| Facility | City | State | ZIP |
|---|---|---|---|
| Oregon State University | Corvallis | Oregon | 97331 |
Find similar trials in Corvallis, OR
By condition
By specialty
By research site
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerPHASE3 · Recruiting · Canadian Cancer Trials Group · Fairbanks, Alaska